RxDoctor Payments Data

Annie Bentley, APRN

Family · London, KYNPI 1447807045

Payments from drug & device makers

$752in general payments, 2019–2025

Across 40 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$253
  • Astellas Pharma US Inc$134
  • AbbVie$87
  • Lilly USA, LLC$64
  • GSK$64
  • Merck$55
  • plus $95 from 5 others

What the payments were for

  • Food & beverage$65287%
  • Education$10013%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$752 in reported general payments places this provider in the 55th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,107
Medicare patients
35
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide65$73,583
JardianceEmpagliflozin37$30,701
TrulicityDulaglutide23$26,072
JanuviaSitagliptin Phosphate19$19,445
LinzessLinaclotide20$14,701
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$2,133
Albuterol Sulfate HfaAlbuterol Sulfate78$1,357
Lubiprostone12$1,127
Levothyroxine Sodium173$1,034
Doxycycline Monohydrate49$939
Ventolin HfaAlbuterol Sulfate12$723
Bupropion XlBupropion Hcl31$703
SynthroidLevothyroxine Sodium11$574
Atorvastatin Calcium135$558
Famotidine78$554

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$253$73,58365 claims
Lilly USA, LLCTrulicity$64$26,07223 claims
MerckJanuvia$55$19,44519 claims
AbbVieLinzess, Synthroid$87$15,27531 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,374 family providers in Kentucky.

Other family in London

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →